Milestone Scientific Inc. (MLSS) Earnings Call Transcripts

Milestone Scientific Inc.'s Latest Earnings Call - Q4 FY2025

In the fourth quarter of 2025, Milestone Scientific Inc. (MLSS:US) reported total revenue of $2.1 million, a 2.2% increase year-over-year, and a net loss of $1.1 million, significantly improved from a $2 million loss in the prior year. For the full fiscal year 2025, revenue totaled $9 million, up 4% from $8.6 million in 2024. Management provided guidance for 2026, expecting total revenue between $9.8 million and $10.2 million, indicating double-digit growth driven by expanding adoption of their dental and medical products, particularly the CompuFlo system, which is projected to contribute $500,000 to $600,000, representing a 400% increase over 2025.

Reported metrics

Guidance from management

Management expects total revenue for 2026 to be between $9.8 million and $10.2 million, with CompuFlo projected to contribute $500,000 to $600,000. This guidance reflects a commitment to achieving double-digit growth and improving operating leverage.

What management said

Yes. So the focus will be on Novitas and First Coast in those 3 respective regions. However, we are already into, I believe, 2 additional [ MAX ] that we're that are part of adviser program. So we are going to be pushing down and pressing down hard on the First Coast of Novitas [ Max ], but also expanding into others.

Yes, that is our plan. However, with issues of ours [indiscernible] anything like that might arise. We still have to look at all of those options to make sure that we are putting in accruals and different things like that, but we have not been affected totally with tariffs or anything like that at this time.

What analysts pressed on

Analysts expressed concerns regarding the sustainability of gross margins and the timeline for international market registrations. There were also questions about the effectiveness of the Dental Ambassador program and its impact on sales.

Main topics on the call

• Revenue Growth and Guidance — Management expects 2026 revenue to be between $9.8 million and $10.2 million, reflecting double-digit growth. CEO Eric Hines emphasized, "Our goal is to reach cash flow breakeven in early 2027 and build real lasting valu...
• CompuFlo System Expansion — The CompuFlo system is seen as a transformative growth driver, with management stating, "We believe CompuFlo represents a transformative growth driver as reimbursement and clinical adoption expand." The system is expecte...
• Dental Ambassador Program Launch — The national launch of the Dental Ambassador program aims to enhance market penetration, with nearly 200 ambassadors signed up. Hines noted, "The goal is somewhere in the neighborhood of a few hundred thousand dollars of...
• Cost Management and Operating Losses — Operating losses improved by 89% in Q4 2025, down to $1.1 million from $2 million in Q4 2024. Management has focused on reducing expenses, with Hines stating, "We went line by line through every expense cut what wasn't m...

Read the full Milestone Scientific Inc. transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 33 Milestone Scientific Inc. earnings call transcripts on record, spanning March 31, 2020 to May 14, 2026. Based on this history, Milestone Scientific Inc. reports quarterly. The most recent call on file is dated May 14, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

MLSS

Exchange

NYSEAM

Country

US

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

33

First call

March 31, 2020

Most recent

May 14, 2026

Reporting cadence

quarterly